MedPath

Comparison of the effect of ?Labetalol and Remifentanil and Dexmedetomidine in control of ?bleeding during head surgery

Phase 3
Recruiting
Conditions
Craniotomy.
Nontraumatic subarachnoid hemorrhage
Registration Number
IRCT20141209020258N167
Lead Sponsor
Vice chancellor for research, Arak University Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
90
Inclusion Criteria

Age 18 to 75 years
ASA Class One and Two
No coagulation disorders
No history of cardiovascular disease
Proper control of blood pressure
Absence of pregnancy
Not addicted to opioids
Body mass index more than 35
Candidate patients for craniotomy

Exclusion Criteria

Dissatisfaction
Existence of allergy to the studied drugs
Platelet count less than 150 thousand
Family history of thromboembolism

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Surgeon satisfaction. Timepoint: After surgery. Method of measurement: Question from the surgeon.;Bleeding. Timepoint: During surgery. Method of measurement: observation.;Mean hemoglobin. Timepoint: Before and 12 hours after surgery. Method of measurement: Hemoglobin blood test(CBC diff).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath